He is a Senior Bioinformatic Scientist at AstraZeneca (Oncology Data Science) that advances early oncology projects by using bioinformatics to refine patient line of sight, mechanism of action, and biomarkers for therapeutics. In addition, he develops innovative data science methods to identify new target opportunities, especially for new small molecule modalities like PROTACs and molecular glues.